This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Ablynx N.v., University Medical Center Hamburg-Eppendorf. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 174 
2 out of 4 Years Active: 2018-2020
Title: Welbeck Owusu Danquah: Innovator in Biological Materials
Introduction
Welbeck Owusu Danquah is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of biological materials, particularly in relation to the P2X7 receptor. With a total of two patents to his name, Danquah's work is paving the way for advancements in therapeutic and diagnostic applications.
Latest Patents
Danquah's latest patents focus on P2X7 receptor antagonists and agonists. These inventions relate to biological materials that target the P2X7 receptor, specifically polypeptides and nucleic acids encoding such polypeptides. The patents detail methods for preparing these polypeptides and host cells capable of expressing them. Furthermore, the compositions, particularly pharmaceutical ones, that include these polypeptides are intended for prophylactic, therapeutic, or diagnostic purposes. The biological materials developed by Danquah inhibit the biological activity of the P2X7 receptor, such as its activation by ATP.
Career Highlights
Throughout his career, Welbeck Owusu Danquah has worked with prominent organizations, including Ablynx N.V. and the University Medical Center Hamburg-Eppendorf. His experience in these institutions has allowed him to refine his expertise in biological materials and their applications in medicine.
Collaborations
Danquah has collaborated with notable colleagues such as
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile